| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Active versus passive anti-cytokine antibody therapy against cytokine-associated chronic diseases
|
Zagury, D
|
|
2003
|
71-72 |
2 |
p. 123-137
15 p.
|
artikel
|
| 2 |
Activin and related proteins in inflammation: Not just interested bystanders
|
Phillips, David J.
|
|
2009
|
71-72 |
2 |
p. 153-164
12 p.
|
artikel
|
| 3 |
Acute induction and priming for cytokine production in lymphocytes
|
Trinchieri, Giorgio
|
|
1996
|
71-72 |
2 |
p. 123-132
10 p.
|
artikel
|
| 4 |
Ad:Specialist in Immunoassay
|
|
|
2003
|
71-72 |
2 |
p. IBC-
1 p.
|
artikel
|
| 5 |
Bad bones, absent smell, selfish testes: The pleiotropic consequences of human FGF receptor mutations
|
Wilkie, Andrew O.M.
|
|
2005
|
71-72 |
2 |
p. 187-203
17 p.
|
artikel
|
| 6 |
Biological and biochemical inhibitors of the NF-κB/Rel proteins and cytokine synthesis
|
Beauparlant, Pierre
|
|
1996
|
71-72 |
2 |
p. 175-190
16 p.
|
artikel
|
| 7 |
Biological monitoring of IFN-β therapy in Multiple Sclerosis
|
Bertolotto, A.
|
|
2015
|
71-72 |
2 |
p. 241-248
8 p.
|
artikel
|
| 8 |
Cell-specific and context-dependent effects of GITR in cancer, autoimmunity, and infection
|
Clouthier, Derek L.
|
|
2014
|
71-72 |
2 |
p. 91-106
16 p.
|
artikel
|
| 9 |
Cellular signaling by fibroblast growth factor receptors
|
Eswarakumar, V.P.
|
|
2005
|
71-72 |
2 |
p. 139-149
11 p.
|
artikel
|
| 10 |
Cellular sources of pathogenic and protective TNF and experimental strategies based on utilization of TNF humanized mice
|
Winsauer, Caroline
|
|
2014
|
71-72 |
2 |
p. 115-123
9 p.
|
artikel
|
| 11 |
Chemokines in cancer
|
Vicari, Alain P
|
|
2002
|
71-72 |
2 |
p. 143-154
12 p.
|
artikel
|
| 12 |
Chemokines shape the immune responses to tuberculosis
|
Slight, Samantha R.
|
|
2013
|
71-72 |
2 |
p. 105-113
9 p.
|
artikel
|
| 13 |
Coinhibitory molecules in cancer biology and therapy
|
Mocellin, Simone
|
|
2013
|
71-72 |
2 |
p. 147-161
15 p.
|
artikel
|
| 14 |
Conference Calendar
|
|
|
2002
|
71-72 |
2 |
p. 197-
1 p.
|
artikel
|
| 15 |
Conference calendar
|
|
|
2003
|
71-72 |
2 |
p. 179-
1 p.
|
artikel
|
| 16 |
Conference calendar
|
|
|
2005
|
71-72 |
2 |
p. III-IV
nvt p.
|
artikel
|
| 17 |
Conference calendarequence weighting, position specific gap penalties and weight
|
|
|
1996
|
71-72 |
2 |
p. 207-208
2 p.
|
artikel
|
| 18 |
Control of invasive growth by hepatocyte growth factor (HGF) and related scatter factors
|
Tamagnone, Luca
|
|
1997
|
71-72 |
2 |
p. 129-142
14 p.
|
artikel
|
| 19 |
Crosstalk between cartilage and bone: When bone cytokines matter
|
Funck-Brentano, Thomas
|
|
2011
|
71-72 |
2 |
p. 91-97
7 p.
|
artikel
|
| 20 |
Cytokine and Interferon Research in Israel
|
Kaempfer, Raymond
|
|
1998
|
71-72 |
2 |
p. 99-108
10 p.
|
artikel
|
| 21 |
Death receptor agonist therapies for cancer, which is the right TRAIL?
|
Holland, Pamela M.
|
|
2014
|
71-72 |
2 |
p. 185-193
9 p.
|
artikel
|
| 22 |
Discussion
|
|
|
1999
|
71-72 |
2 |
p. 159-171
13 p.
|
artikel
|
| 23 |
Discussion
|
|
|
1998
|
71-72 |
2 |
p. 167-173
7 p.
|
artikel
|
| 24 |
Discussion
|
|
|
1998
|
71-72 |
2 |
p. 175-181
7 p.
|
artikel
|
| 25 |
Divergent effects of type-I interferons on regulatory T cells
|
Piconese, Silvia
|
|
2015
|
71-72 |
2 |
p. 133-141
9 p.
|
artikel
|
| 26 |
Dual role of tumor necrosis factor alpha in brain injury
|
Shohami, Esther
|
|
1999
|
71-72 |
2 |
p. 119-130
12 p.
|
artikel
|
| 27 |
Ectodysplasin A (EDA) – EDA receptor signalling and its pharmacological modulation
|
Kowalczyk-Quintas, Christine
|
|
2014
|
71-72 |
2 |
p. 195-203
9 p.
|
artikel
|
| 28 |
Editorial
|
Battistini, Angela
|
|
2015
|
71-72 |
2 |
p. 95-97
3 p.
|
artikel
|
| 29 |
Editorial Board
|
|
|
2009
|
71-72 |
2 |
p. CO2-
1 p.
|
artikel
|
| 30 |
Editorial Board
|
|
|
2008
|
71-72 |
2 |
p. CO2-
1 p.
|
artikel
|
| 31 |
Editorial Board
|
|
|
2011
|
71-72 |
2 |
p. CO2-
1 p.
|
artikel
|
| 32 |
Editorial Board
|
|
|
2013
|
71-72 |
2 |
p. CO2-
1 p.
|
artikel
|
| 33 |
Editorial Board and Publication information
|
|
|
2015
|
71-72 |
2 |
p. IFC-
1 p.
|
artikel
|
| 34 |
Editorial Board and Publication information
|
|
|
2014
|
71-72 |
2 |
p. CO2-
1 p.
|
artikel
|
| 35 |
Editorial Board/Publication info.
|
|
|
2003
|
71-72 |
2 |
p. IFC-
1 p.
|
artikel
|
| 36 |
Editorial Board/Publication info.
|
|
|
2005
|
71-72 |
2 |
p. CO2-
1 p.
|
artikel
|
| 37 |
Endogenous type I interferons as a defense against tumors
|
Gresser, Ion
|
|
2002
|
71-72 |
2 |
p. 111-118
8 p.
|
artikel
|
| 38 |
Facts and Faces
|
|
|
2002
|
71-72 |
2 |
p. 195-196
2 p.
|
artikel
|
| 39 |
Facts and faces
|
|
|
1996
|
71-72 |
2 |
p. 203-206
4 p.
|
artikel
|
| 40 |
Facts and faces
|
|
|
1997
|
71-72 |
2 |
p. 159-160
2 p.
|
artikel
|
| 41 |
FGF23 and disorders of phosphate homeostasis
|
Yu, Xijie
|
|
2005
|
71-72 |
2 |
p. 221-232
12 p.
|
artikel
|
| 42 |
FGF signaling in flies and worms: More and more relevant to vertebrate biology
|
Huang, Peng
|
|
2005
|
71-72 |
2 |
p. 151-158
8 p.
|
artikel
|
| 43 |
FGF signaling in the developing endochondral skeleton
|
Ornitz, David M.
|
|
2005
|
71-72 |
2 |
p. 205-213
9 p.
|
artikel
|
| 44 |
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis
|
Presta, Marco
|
|
2005
|
71-72 |
2 |
p. 159-178
20 p.
|
artikel
|
| 45 |
Fibroblast growth factor homologous factors: Evolution, structure, and function
|
Goldfarb, Mitchell
|
|
2005
|
71-72 |
2 |
p. 215-220
6 p.
|
artikel
|
| 46 |
Fibroblast growth factor signaling in tumorigenesis
|
Grose, Richard
|
|
2005
|
71-72 |
2 |
p. 179-186
8 p.
|
artikel
|
| 47 |
Ghrelin: a metabolic signal affecting the reproductive system
|
Lorenzi, Teresa
|
|
2009
|
71-72 |
2 |
p. 137-152
16 p.
|
artikel
|
| 48 |
GM-CSF-based cellular vaccines: a review of the clinical experience
|
Borrello, Ivan
|
|
2002
|
71-72 |
2 |
p. 185-193
9 p.
|
artikel
|
| 49 |
Growth factor based therapies and intestinal disease: Is glucagon-like peptide-2 the new way forward?
|
Yazbeck, Roger
|
|
2009
|
71-72 |
2 |
p. 175-184
10 p.
|
artikel
|
| 50 |
Growth factors and cytokines in health and disease
|
Sporn, Michael B.
|
|
1997
|
71-72 |
2 |
p. 157-
1 p.
|
artikel
|
| 51 |
High efficiency targeting of IFN-α activity: Possible applications in fighting tumours and infections
|
Uzé, Gilles
|
|
2015
|
71-72 |
2 |
p. 179-182
4 p.
|
artikel
|
| 52 |
IκB kinase β (IKKβ/IKK2/IKBKB)—A key molecule in signaling to the transcription factor NF-κB
|
Schmid, Johannes A.
|
|
2008
|
71-72 |
2 |
p. 157-165
9 p.
|
artikel
|
| 53 |
IFN-β and multiple sclerosis: Cross-talking of immune cells and integration of immunoregulatory networks
|
Severa, Martina
|
|
2015
|
71-72 |
2 |
p. 229-239
11 p.
|
artikel
|
| 54 |
IFN-β and multiple sclerosis: From etiology to therapy and back
|
Annibali, V.
|
|
2015
|
71-72 |
2 |
p. 221-228
8 p.
|
artikel
|
| 55 |
IFN-γ Expression in Macrophages and Its Possible Biological Significance
|
Gessani, Sandra
|
|
1998
|
71-72 |
2 |
p. 117-123
7 p.
|
artikel
|
| 56 |
IGF2: Epigenetic regulation and role in development and disease
|
Chao, Wendy
|
|
2008
|
71-72 |
2 |
p. 111-120
10 p.
|
artikel
|
| 57 |
I listened to my grass roots, but heard only murmurs of discontent
|
Friedman, Robert M.
|
|
1997
|
71-72 |
2 |
p. 101-
1 p.
|
artikel
|
| 58 |
IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer
|
Neurath, Markus F.
|
|
2011
|
71-72 |
2 |
p. 83-89
7 p.
|
artikel
|
| 59 |
Immunostimulatory cytokines in somatic cells and gene therapy of cancer
|
Mackensen, Andreas
|
|
1997
|
71-72 |
2 |
p. 119-128
10 p.
|
artikel
|
| 60 |
Inhibition of death receptor signaling by bacterial gut pathogens
|
Giogha, Cristina
|
|
2014
|
71-72 |
2 |
p. 235-243
9 p.
|
artikel
|
| 61 |
Inhibition of insulin receptor signaling by TNF: Potential role in obesity and non-insulin-dependent diabetes mellitus
|
Skolnik, Edward Y.
|
|
1996
|
71-72 |
2 |
p. 161-173
13 p.
|
artikel
|
| 62 |
Inhibition of the IL-6 signaling pathway: A strategy to combat chronic inflammatory diseases and cancer
|
Ataie-Kachoie, Parvin
|
|
2013
|
71-72 |
2 |
p. 163-173
11 p.
|
artikel
|
| 63 |
Interferon-γ: A historical perspective
|
Billiau, Alfons
|
|
2009
|
71-72 |
2 |
p. 97-113
17 p.
|
artikel
|
| 64 |
Interferon-alpha in tumor immunity and immunotherapy
|
Belardelli, Filippo
|
|
2002
|
71-72 |
2 |
p. 119-134
16 p.
|
artikel
|
| 65 |
Interferon and cytokine responses to SARS-coronavirus infection
|
Thiel, Volker
|
|
2008
|
71-72 |
2 |
p. 121-132
12 p.
|
artikel
|
| 66 |
Interferon gamma: A master regulator of atherosclerosis
|
McLaren, James E.
|
|
2009
|
71-72 |
2 |
p. 125-135
11 p.
|
artikel
|
| 67 |
Interleukin-2 and interleukin-15: immunotherapy for cancer
|
Fehniger, Todd A
|
|
2002
|
71-72 |
2 |
p. 169-183
15 p.
|
artikel
|
| 68 |
Interleukin 15 as a promising candidate for tumor immunotherapy
|
Jakobisiak, Marek
|
|
2011
|
71-72 |
2 |
p. 99-108
10 p.
|
artikel
|
| 69 |
Interleukin-17 family and IL-17 receptors
|
Moseley, T.A.
|
|
2003
|
71-72 |
2 |
p. 155-174
20 p.
|
artikel
|
| 70 |
Interleukin-21 (IL-21)-mediated pathways in T cell-mediated disease
|
Monteleone, Giovanni
|
|
2009
|
71-72 |
2 |
p. 185-191
7 p.
|
artikel
|
| 71 |
Interleukin-12 in anti-tumor immunity and immunotherapy
|
Colombo, Mario P
|
|
2002
|
71-72 |
2 |
p. 155-168
14 p.
|
artikel
|
| 72 |
Interleukin-18: Perspectives on the Newest Interleukin
|
Gillespie, Matthew T
|
|
1998
|
71-72 |
2 |
p. 109-116
8 p.
|
artikel
|
| 73 |
Introduction: Cytokines and Cancer
|
Colombo, Mario P
|
|
2002
|
71-72 |
2 |
p. 93-94
2 p.
|
artikel
|
| 74 |
Introduction to the special FGF issue
|
Basilico, Claudio
|
|
2005
|
71-72 |
2 |
p. 105-106
2 p.
|
artikel
|
| 75 |
Keratinocyte Growth Factor: A Unique Player in Epithelial Repair Processes
|
Werner, Sabine
|
|
1998
|
71-72 |
2 |
p. 153-165
13 p.
|
artikel
|
| 76 |
Latent transforming growth factor-β binding proteins (LTBPs)—structural extracellular matrix proteins for targeting TGF-β action
|
Saharinen, Juha
|
|
1999
|
71-72 |
2 |
p. 99-117
19 p.
|
artikel
|
| 77 |
Long pentraxins: an emerging group of proteins with diverse functions
|
Goodman, Adam R.
|
|
1996
|
71-72 |
2 |
p. 191-202
12 p.
|
artikel
|
| 78 |
Lymphotoxin and TNF: How it all began—A tribute to the travelers
|
Ruddle, Nancy H.
|
|
2014
|
71-72 |
2 |
p. 83-89
7 p.
|
artikel
|
| 79 |
Lymphotoxin organizes contributions to host defense and metabolic illness from innate lymphoid cells
|
Upadhyay, Vaibhav
|
|
2014
|
71-72 |
2 |
p. 227-233
7 p.
|
artikel
|
| 80 |
Matrix metalloproteinase8 has a central role in inflammatory disorders and cancer progression
|
Dejonckheere, Eline
|
|
2011
|
71-72 |
2 |
p. 73-81
9 p.
|
artikel
|
| 81 |
Mechanisms underlying differential responses to FGF signaling
|
Dailey, Lisa
|
|
2005
|
71-72 |
2 |
p. 233-247
15 p.
|
artikel
|
| 82 |
MicroRNAs in virus-induced tumorigenesis and IFN system
|
Fiorucci, Gianna
|
|
2015
|
71-72 |
2 |
p. 183-194
12 p.
|
artikel
|
| 83 |
Mislocalization of the interferon inducible protein IFI16 by environmental insults: Implications in autoimmunity
|
Bawadekar, Mandar
|
|
2015
|
71-72 |
2 |
p. 213-219
7 p.
|
artikel
|
| 84 |
Necrosis-dependent and independent signaling of the RIP kinases in inflammation
|
Moriwaki, Kenta
|
|
2014
|
71-72 |
2 |
p. 167-174
8 p.
|
artikel
|
| 85 |
Nef, the shuttling molecular adaptor of HIV, influences the cytokine network
|
Percario, Zulema Antonia
|
|
2015
|
71-72 |
2 |
p. 159-173
15 p.
|
artikel
|
| 86 |
Neutralizing interferon alpha as a therapeutic approach to autoimmune diseases
|
Stewart, Timothy A.
|
|
2003
|
71-72 |
2 |
p. 139-154
16 p.
|
artikel
|
| 87 |
New perspectives on type I IFNs in cancer
|
Gajewski, Thomas F.
|
|
2015
|
71-72 |
2 |
p. 175-178
4 p.
|
artikel
|
| 88 |
New roles for the BLyS/BAFF family in antigen-experienced B cell niches
|
Goenka, Radhika
|
|
2014
|
71-72 |
2 |
p. 107-113
7 p.
|
artikel
|
| 89 |
NK cells and interferons
|
Paolini, Rossella
|
|
2015
|
71-72 |
2 |
p. 113-120
8 p.
|
artikel
|
| 90 |
[No title]
|
Hiscott, John
|
|
2009
|
71-72 |
2 |
p. 95-
1 p.
|
artikel
|
| 91 |
Novel PDGF family members: PDGF-C and PDGF-D
|
Li, Xuri
|
|
2003
|
71-72 |
2 |
p. 91-98
8 p.
|
artikel
|
| 92 |
One or two cytokine societies?
|
|
|
1996
|
71-72 |
2 |
p. 121-
1 p.
|
artikel
|
| 93 |
On intuition and the discovery of interferon
|
Gresser, Ion
|
|
2015
|
71-72 |
2 |
p. 99-101
3 p.
|
artikel
|
| 94 |
Pattern recognition receptors—Molecular orchestrators of inflammation in inflammatory bowel disease
|
Walsh, David
|
|
2013
|
71-72 |
2 |
p. 91-104
14 p.
|
artikel
|
| 95 |
Pharmacogenomics of interferon-β in multiple sclerosis: What has been accomplished and how can we ensure future progress?
|
Carlson, Rebecca J.
|
|
2015
|
71-72 |
2 |
p. 249-261
13 p.
|
artikel
|
| 96 |
Phospholipase C-γ1: Regulation of enzyme function and role in growth factor-dependent signal transduction
|
Kamat, Asha
|
|
1997
|
71-72 |
2 |
p. 109-117
9 p.
|
artikel
|
| 97 |
Pleiotropic Functions of Neurotrophins in Development
|
Tessarollo, Lino
|
|
1998
|
71-72 |
2 |
p. 125-137
13 p.
|
artikel
|
| 98 |
RANKL/RANK – From bone physiology to breast cancer
|
Sigl, Verena
|
|
2014
|
71-72 |
2 |
p. 205-214
10 p.
|
artikel
|
| 99 |
Raves and risks for erythropoietin
|
Maiese, Kenneth
|
|
2008
|
71-72 |
2 |
p. 145-155
11 p.
|
artikel
|
| 100 |
Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis
|
Shi-Wen, Xu
|
|
2008
|
71-72 |
2 |
p. 133-144
12 p.
|
artikel
|
| 101 |
Role of type I interferon in inducing a protective immune response: Perspectives for clinical applications
|
Rizza, Paola
|
|
2015
|
71-72 |
2 |
p. 195-201
7 p.
|
artikel
|
| 102 |
Roles for TNF-receptor associated factor 3 (TRAF3) in lymphocyte functions
|
Yi, Zuoan
|
|
2014
|
71-72 |
2 |
p. 147-156
10 p.
|
artikel
|
| 103 |
Roles of TGFβ signaling in epidermal/appendage development
|
Li, Allen G.
|
|
2003
|
71-72 |
2 |
p. 99-111
13 p.
|
artikel
|
| 104 |
Signaling via the insulin-like growth factor-I receptor: Does it differ from insulin receptor signaling?
|
Blakesley, Vicky A.
|
|
1996
|
71-72 |
2 |
p. 153-159
7 p.
|
artikel
|
| 105 |
Snail/Gfi-1 (SNAG) family zinc finger proteins in transcription regulation, chromatin dynamics, cell signaling, development, and disease
|
Chiang, Cindy
|
|
2013
|
71-72 |
2 |
p. 123-131
9 p.
|
artikel
|
| 106 |
Stat5a and Stat5b: fraternal twins of signal transduction and transcriptional activation
|
Grimley, Philip M.
|
|
1999
|
71-72 |
2 |
p. 131-157
27 p.
|
artikel
|
| 107 |
Structural basis for fibroblast growth factor receptor activation
|
Mohammadi, Moosa
|
|
2005
|
71-72 |
2 |
p. 107-137
31 p.
|
artikel
|
| 108 |
Structural conservation of interferon gamma among vertebrates
|
Savan, Ram
|
|
2009
|
71-72 |
2 |
p. 115-124
10 p.
|
artikel
|
| 109 |
TGF-β: the missing link in CD4+CD25+ regulatory T cell-mediated immunosuppression
|
Chen, WanJun
|
|
2003
|
71-72 |
2 |
p. 85-89
5 p.
|
artikel
|
| 110 |
The CBM signalosome: Potential therapeutic target for aggressive lymphoma?
|
Yang, Chenghua
|
|
2014
|
71-72 |
2 |
p. 175-183
9 p.
|
artikel
|
| 111 |
The emerging role of Interleukin 27 in inflammatory arthritis and bone destruction
|
Adamopoulos, Iannis E.
|
|
2013
|
71-72 |
2 |
p. 115-121
7 p.
|
artikel
|
| 112 |
The epidermal growth factor receptor and its ligands as therapeutic targets in human tumors
|
Rusch, Valerie
|
|
1996
|
71-72 |
2 |
p. 133-141
9 p.
|
artikel
|
| 113 |
The epidermal growth factor receptor and its ligands in female reproduction: Insights from rodent models
|
Schneider, Marlon R.
|
|
2008
|
71-72 |
2 |
p. 173-181
9 p.
|
artikel
|
| 114 |
The implication of adiponectin and resistin in gastrointestinal diseases
|
Tiaka, Elisavet K.
|
|
2011
|
71-72 |
2 |
p. 109-119
11 p.
|
artikel
|
| 115 |
The in vivo significance of necroptosis: Lessons from exploration of caspase-8 function
|
Wallach, David
|
|
2014
|
71-72 |
2 |
p. 157-165
9 p.
|
artikel
|
| 116 |
The Lymphotoxin Network: Orchestrating a Type I interferon response to optimize adaptive immunity
|
Gommerman, Jennifer L.
|
|
2014
|
71-72 |
2 |
p. 139-145
7 p.
|
artikel
|
| 117 |
The mode of ceramide action: The alkyl chain protrusion model
|
Kränke, Martin
|
|
1997
|
71-72 |
2 |
p. 103-107
5 p.
|
artikel
|
| 118 |
The potential autocrine/paracrine roles of ghrelin and its receptor in hormone-dependent cancer
|
Jeffery, Penny L.
|
|
2003
|
71-72 |
2 |
p. 113-122
10 p.
|
artikel
|
| 119 |
The role of cytokines in the initiation and progression of myelofibrosis
|
Hasselbalch, Hans C.
|
|
2013
|
71-72 |
2 |
p. 133-145
13 p.
|
artikel
|
| 120 |
The Role of Helper T Cell Subsets in Autoimmune Diseases
|
Lafaille, Juan J
|
|
1998
|
71-72 |
2 |
p. 139-151
13 p.
|
artikel
|
| 121 |
The role of lymphotoxin signaling in the development of autoimmune pancreatitis and associated secondary extra-pancreatic pathologies
|
Seleznik, Gitta Maria
|
|
2014
|
71-72 |
2 |
p. 125-137
13 p.
|
artikel
|
| 122 |
The roles of IFNγ in protection against tumor development and cancer immunoediting
|
Ikeda, Hiroaki
|
|
2002
|
71-72 |
2 |
p. 95-109
15 p.
|
artikel
|
| 123 |
The 14th International TNF Conference, Québec City, Canada – Des Progrės Récents aux Défis Futurs (Recent Advances toward Future Challenges)
|
Burkly, Linda
|
|
2014
|
71-72 |
2 |
p. 77-81
5 p.
|
artikel
|
| 124 |
The TWEAK-Fn14 pathway: A potent regulator of skeletal muscle biology in health and disease
|
Tajrishi, Marjan M.
|
|
2014
|
71-72 |
2 |
p. 215-225
11 p.
|
artikel
|
| 125 |
The type-I interferon receptor. The long and short of it
|
Domanski, Paul
|
|
1996
|
71-72 |
2 |
p. 143-151
9 p.
|
artikel
|
| 126 |
The use of interferon in melanoma patients: A systematic review
|
Di Trolio, Rossella
|
|
2015
|
71-72 |
2 |
p. 203-212
10 p.
|
artikel
|
| 127 |
Toll-like receptor 3, RIG-I-like receptors and the NLRP3 inflammasome: Key modulators of innate immune responses to double-stranded RNA viruses
|
Yu, Man
|
|
2011
|
71-72 |
2 |
p. 63-72
10 p.
|
artikel
|
| 128 |
Transformation, translation and TRAIL: An unexpected intersection
|
White-Gilbertson, Shai
|
|
2008
|
71-72 |
2 |
p. 167-172
6 p.
|
artikel
|
| 129 |
TSG-6: An IL-1 /TNF-inducible protein with anti-inflammatory activity
|
Wisniewski, Hans-Georg
|
|
1997
|
71-72 |
2 |
p. 143-156
14 p.
|
artikel
|
| 130 |
Tumor necrosis factor-α as a therapeutic target for diabetic nephropathy
|
Navarro-González, Juan F.
|
|
2009
|
71-72 |
2 |
p. 165-173
9 p.
|
artikel
|
| 131 |
Tumor necrosis factor or tumor promoting factor?
|
Balkwill, Fran
|
|
2002
|
71-72 |
2 |
p. 135-141
7 p.
|
artikel
|
| 132 |
Twenty-five years of type I interferon-based treatment: A critical analysis of its therapeutic use
|
Antonelli, Guido
|
|
2015
|
71-72 |
2 |
p. 121-131
11 p.
|
artikel
|
| 133 |
Type I IFN – A blunt spear in fighting HIV-1 infection
|
Acchioni, Chiara
|
|
2015
|
71-72 |
2 |
p. 143-158
16 p.
|
artikel
|
| 134 |
Type I IFN family members: Similarity, differences and interaction
|
Capobianchi, Maria Rosaria
|
|
2015
|
71-72 |
2 |
p. 103-111
9 p.
|
artikel
|
| 135 |
Whole body hyperthermia cytokine induction: a review, and unifying hypothesis for myeloprotection in the setting of cytotoxic therapy
|
Katschinski, D.M.
|
|
1999
|
71-72 |
2 |
p. 93-97
5 p.
|
artikel
|
Tijdschrift beschrijving